Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
33,058
Sort by:
Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022
US$ 2,635.00
... . This decade, many opportunities will arise. EIGHT WAYS LYOPHILISATION FOR PHARMACEUTICALS: PRODUCTS AND SERVICES MARKET 2012-2022 HELPS YOU ... (EU5), India and China Profiles of 5 leading companies - discussions of activities, products and outlooks Opinions on the sector, including our interviews with ...
August 2012
130 pages
Competitor Analysis: Malaria Vaccines & Therapeutics
US$ 390.00
... description The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and ... regions. Each year more than 350 million new cases of Malaria occur, it is one of the world’s most common diseases. People with ...
August 2012
64 pages
Competitor Analysis: CMV Vaccines & Therapeutics
US$ 247.00
... approved for treatment or prevention of CMV disease, such as ganciclovir, or hyperimmune globulin preparations, but no specific CMV vaccine is approved. The present Competitor Analysis describes the R&D pipeline of new molecular entities including vaccines, monoclonal antibodies, peptides, cellular therapy ...
August 2012
23 pages
Pharma Reputations: Managing Perceptions
US$ 645.00
Pharma is no stranger to the idea of nurturing and defending corporate reputations. But in this hyper-connected world, Likes and Tweets are replacing traditional authority sources and creating a compl...
July 2012
69 pages
Pharma's Future Role in CME
US$ 595.00
... Dossier report: Pharma’s Future Role in CME. REPORT OVERVIEW Save time and effort by reviewing forecasts from 10 leading figures in the US and European CME fields ... role in future CME productions, or strategically direct these from the background. KEY REPORT FEATURES Recent and expected US and European CME regulations Latest pharma ...
July 2012
62 pages
World Vaccines Market 2012-2022
US$ 2,635.00
... and branded groups - including Prevnar-13, Pentacel, Gardasil and Fluzone - perform to 2022? Our investigation shows business research and analysis with sales ... receive 91 tables, 63 charts and a research interview. Eight ways World Vaccines Market 2012-2022 helps you In particular, our study gives you ...
July 2012
199 pages
Latest Guide to Chinese Pharmaceutical GMP Regulations
US$ 750.00
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US$246 billion)...
July 2012
135 pages
OTC Triptans in Germany
US$ 990.00
... for a considerable further increase of category value sales in Germany in 2011. Euromonitor International's OTC Triptans in Germany report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving change ...
July 2012
27 pages
Cempra: “GAIN from Drugs for Bad Bugs”
US$ 140.00
Drug resistance is a growing concern worldwide and Cempra (CEMP) is one of our lead recommendations ... offer an attractive investment opportunity in this therapy class. CEMP’s lead drug, 1. Solithromycin (CEM-101, PhIII, CABP; PhII cUTI) ... released on 2nd July, 2012 on CEMP titled “GAIN from Drugs for Bad Bugs”
July 2012
9 pages
Competitor Analysis: Dengue Virus Vaccines and Therapeutics
US$ 243.00
... of Dengue fever and of therapeutics for treatment of Dengue fever. In addition, the report lists company-specific R&D pipelines of Dengue Virus Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...
July 2012
27 pages
China Genetic Engineering Drug Industry Report, 2011-2012
US$ 1,900.00
China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...
June 2012
80 pages
Needle-Free Drug Injection Systems and Safety Syringes: Market Research Report
US$ 4,600.00
This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides ... , Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, ...
June 2012
504 pages
Pharma sales force shape, size and structure — where next?
US$ 595.00
... — Pharma sales force shape, size and structure — where next? — analyses the key issues influencing sales force objectives and structure; how some pharma companies have restructured their sales and marketing channels, and whether these changes have been successful or not. Report Overview Pharma sales force shape, size ...
June 2012
68 pages
Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022
US$ 2,635.00
Report Details Antibacterial medicines - discover performance and commercial prospects of companies How are leading companies in the antibacterial drugs market performing? Visiongain's new report gives you data, analyses and revenue predictions for antibacterial manufacturers. See how top companies ...
June 2012
185 pages
Prioritizing Generic Drug development pipeline – The top Fifty Opportunities
US$ 5,000.00
... crucial aspects of growth strategy for a generic company or an Active Pharmaceutical Ingredient manufacturing ... recently approved or are in late stage development / Filed but with significantly success probability ... / therapeutic value compared to marketed drugs Anticipated competition in the therapy and ...
June 2012
100 pages
OTC Drug Market in India 2012
US$ 950.00
... days after order is placed. Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position ... tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign ...
June 2012
85 pages
World OTC Pharmaceutical Market 2012-2022
US$ 2,635.00
... , 35 charts and two research interviews. Nine ways World OTC Pharmaceutical Market 2012-2022 helps you In particular, our study gives ... , and others, discovering activities and outlooks Review prospects for Rx-to-OTC switching by therapeutic area Investigate competition and opportunities influencing sales ...
June 2012
147 pages
Production Situation of Vitamin E in China
US$ 1,620.00
In volume of transaction, Vitamin E is one of the world's top three vitamins with annual global market volume of nearly USD1 billion, thanks to the wide range of applications in feed, medicine and foo...
June 2012
20 pages
Competitor Analysis: RSV Vaccines and Therapeutics
US$ 315.00
Competitor Analysis: Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics The present Competitive Intelligence Report about RSV Vaccines & Therapeutics provides a ... RSV disease in infants and children at high risk for severe lung disease from RSV, a RSV vaccine still is not on the market. A number ...
June 2012
30 pages
Asia Pacific Pharma Sector Analysis
US$ 1,300.00
The Asia-Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. In the recent years, the demand for healthcare services has risen among the regio...
May 2012
160 pages
The Chinese R&D Landscape - Pharmaceuticals
US$ 1,200.00
R&D in China in the field of pharmaceuticals* has surged over the last decade. This report seeks to answer the following questions related to this surge in R&D:
Where in China does the R&a...
May 2012
12 pages
Effective Sales and Marketing Strategies for Orphan Drugs
US$ 695.00
The real potential for orphan drug pharma marketing With drug pipelines moving from essential products to niche therapies, large pharma companies are increasingly attracted to the prospective high de...
May 2012
117 pages
Insulin Market Forecast to 2015
US$ 400.00
In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global mar...
May 2012
42 pages
Calming and Sleeping in Thailand
US$ 990.00
Claiming and sleeping products was previously present in Thailand in the form of some herbal calming and sleeping products, such as Baracol, Calmaco, Passiflora and Cassia ... . Consequently, these herbal calming and sleeping products was banned for sale over the counter... Euromonitor International's Calming and Sleeping in Thailand report offers a comprehensive ...
May 2012
23 pages
Emergency Contraception in Slovakia
US$ 990.00
... as a regular method of contraception. An overall decrease in value growth was evident each year as a result of changing lifestyles of females. In general emergency contraception is considered a last resort for many women as such medication has the... Euromonitor International's Emergency Contraception in Slovakia report offers a comprehensive ...
May 2012
20 pages
